M2 EQUITYBITES-August 19, 2019-Elekta announces treatment of first patient by
Sunnybrook Health Sciences Centre with Elekta Unity MR-Linac
Global Banking News-August 19, 2019-Elekta announces treatment of first patient by
Sunnybrook Health Sciences Centre with Elekta Unity MR-Linac
NORDIC BUSINESS REPORT-August 19, 2019-Elekta announces treatment of first patient by
Sunnybrook Health Sciences Centre with Elekta Unity MR-Linac
M2 PHARMA-August 19, 2019-Elekta announces treatment of first patient by
Sunnybrook Health Sciences Centre with Elekta Unity MR-Linac
WORLDWIDE COMPUTER PRODUCTS NEWS-August 19, 2019-Elekta announces treatment of first patient by
Sunnybrook Health Sciences Centre with Elekta Unity MR-Linac
(2)
Sunnybrook Health Sciences Centre, Department of Surgery, Toronto, J Urol Res 2017:4:1090.
The findings of the study challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients, according to lead author Zachary Bouck, MPH, of the department of medicine at
Sunnybrook Health Sciences Centre in Toronto, and his coauthors.
Gershon, M.D., from
Sunnybrook Health Sciences Centre in Toronto, and colleagues described trends in use of end-of-life care strategies by people with advanced COPD.
Sunnybrook Health Sciences Centre Research Ethics Board approved the study protocol.
Ross Tilley Burn Centre,
Sunnybrook Health Sciences Centre and Division of Plastic and Reconstructive Surgery, Department of Surgery, Faculty of Medicine, University of Toronto, Canada
This study was approved by the institutional review board at
Sunnybrook Health Sciences Centre, Toronto, Canada.